These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32179690)

  • 1. Small-molecule covalent bond formation at tyrosine creates a binding site and inhibits activation of Ral GTPases.
    Bum-Erdene K; Liu D; Gonzalez-Gutierrez G; Ghozayel MK; Xu D; Meroueh SO
    Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7131-7139. PubMed ID: 32179690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent Fragment Screening Identifies Rgl2 RalGEF Cysteine for Targeted Covalent Inhibition of Ral GTPase Activation.
    Bum-Erdene K; Ghozayel MK; Xu D; Meroueh SO
    ChemMedChem; 2022 Mar; 17(6):e202100750. PubMed ID: 35061330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant overexpression of the Rgl2 Ral small GTPase-specific guanine nucleotide exchange factor promotes pancreatic cancer growth through Ral-dependent and Ral-independent mechanisms.
    Vigil D; Martin TD; Williams F; Yeh JJ; Campbell SL; Der CJ
    J Biol Chem; 2010 Nov; 285(45):34729-40. PubMed ID: 20801877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAL GTPases: Biology and Potential as Therapeutic Targets in Cancer.
    Yan C; Theodorescu D
    Pharmacol Rev; 2018 Jan; 70(1):1-11. PubMed ID: 29196555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RalA activation at nascent lamellipodia of epidermal growth factor-stimulated Cos7 cells and migrating Madin-Darby canine kidney cells.
    Takaya A; Ohba Y; Kurokawa K; Matsuda M
    Mol Biol Cell; 2004 Jun; 15(6):2549-57. PubMed ID: 15034142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine phosphorylation of RalGDS by c-Met receptor blocks its interaction with Ras.
    Wong R; Feig LA
    Biochem Biophys Res Commun; 2016 Nov; 480(3):468-473. PubMed ID: 27773821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugging the Ral GTPase.
    Yan C; Jones DN; Theodorescu D
    Small GTPases; 2015; 6(3):157-9. PubMed ID: 26280620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel guanine nucleotide exchange factor GEFmeso of Drosophila melanogaster interacts with Ral and Rho GTPase Cdc42.
    Blanke S; Jäckle H
    FASEB J; 2006 Apr; 20(6):683-91. PubMed ID: 16581976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The RalGEF/Ral pathway: evaluating an intervention opportunity for Ras cancers.
    Cooper JM; Bodemann BO; White MA
    Enzymes; 2013; 34 Pt. B():137-56. PubMed ID: 25034103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural study of the Cdc25 domain from Ral-specific guanine-nucleotide exchange factor RalGPS1a.
    Peng W; Xu J; Guan X; Sun Y; Zhang XC; Li X; Rao Z
    Protein Cell; 2011 Apr; 2(4):308-19. PubMed ID: 21494904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ral GTPases: crucial mediators of exocytosis and tumourigenesis.
    Shirakawa R; Horiuchi H
    J Biochem; 2015 May; 157(5):285-99. PubMed ID: 25796063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and characterization of small molecules that target the GTPase Ral.
    Yan C; Liu D; Li L; Wempe MF; Guin S; Khanna M; Meier J; Hoffman B; Owens C; Wysoczynski CL; Nitz MD; Knabe WE; Ahmed M; Brautigan DL; Paschal BM; Schwartz MA; Jones DN; Ross D; Meroueh SO; Theodorescu D
    Nature; 2014 Nov; 515(7527):443-7. PubMed ID: 25219851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ selectivity profiling and crystal structure of SML-8-73-1, an active site inhibitor of oncogenic K-Ras G12C.
    Hunter JC; Gurbani D; Ficarro SB; Carrasco MA; Lim SM; Choi HG; Xie T; Marto JA; Chen Z; Gray NS; Westover KD
    Proc Natl Acad Sci U S A; 2014 Jun; 111(24):8895-900. PubMed ID: 24889603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ras-dependent activation of the small GTPase Ral.
    Wolthuis RM; Zwartkruis F; Moen TC; Bos JL
    Curr Biol; 1998 Apr; 8(8):471-4. PubMed ID: 9550702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of a new family of guanine nucleotide exchange factors for the ras-related GTPase Ral.
    Rebhun JF; Chen H; Quilliam LA
    J Biol Chem; 2000 May; 275(18):13406-10. PubMed ID: 10747847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RAL signaling network: Cancer and beyond.
    Apken LH; Oeckinghaus A
    Int Rev Cell Mol Biol; 2021; 361():21-105. PubMed ID: 34074494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ras-independent activation of Ral by a Ca(2+)-dependent pathway.
    Hofer F; Berdeaux R; Martin GS
    Curr Biol; 1998 Jul; 8(14):839-42. PubMed ID: 9663394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of Ral GTPase in v-Src-induced phospholipase D activation.
    Jiang H; Luo JQ; Urano T; Frankel P; Lu Z; Foster DA; Feig LA
    Nature; 1995 Nov; 378(6555):409-12. PubMed ID: 7477381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The B cell antigen receptor controls AP-1 and NFAT activity through Ras-mediated activation of Ral.
    de Gorter DJ; Vos JC; Pals ST; Spaargaren M
    J Immunol; 2007 Feb; 178(3):1405-14. PubMed ID: 17237388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Ral GTPases Using a Stapled Peptide Approach.
    Thomas JC; Cooper JM; Clayton NS; Wang C; White MA; Abell C; Owen D; Mott HR
    J Biol Chem; 2016 Aug; 291(35):18310-25. PubMed ID: 27334922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.